COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20210702051763N1


Column Value
Trial registration number IRCT20210702051763N1
Full text link
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Teamur Aghamolaei

Contact
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

teaghamolaei@gmail.com

Registration date
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-08-14

Recruitment status
Last imported at : Aug. 23, 2022, 11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Factorial

Masking
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

People aged 18-65 confirmation of Covid-19 infection by RT-PCR test completing informed consent less than 48 hours have passed since the patient was hospitalized no skin or gastrointestinal allergies due to taking multivitamin supplements, vitamin D, and magnesium people with more than 30 breaths per minute and less than 93% oxygen saturation in room air and sea level.

Exclusion criteria
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Pregnancy or lactation take a daily multivitamin or take a vitamin D or magnesium supplement in the last month participating in other clinical studies renal failure or dialysis, severe liver disease or cirrhosis known diagnosis of hypercalcemia patients who discharged from the hospital less than 24 hours after the start of the intervention history of kidney stones in the last year transfer the patient to the ICU baseline vitamin D levels above 80 ng/ml baseline magnesium levels above 2.6 mg/dl.

Number of arms
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

4

Funding
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Bandare-abbas University of Medical Sciences

Inclusion age min
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

65

Countries
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Mild/moderate disease at enrollment

Severity scale
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2: Mild/moderate disease at enrollment

Total sample size
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

104

primary outcome
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Myalgia fever dry cough Shortness of breath Percentage of oxygen saturation WBC CRP MDA TAC Headache mortality Neutrophil count Lymphocyte count The ratio of neutrophils to lymphocytes 25 hydroxyvitamin D magnesium

Notes
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : Sept. 13, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 1370, "treatment_name": "Vitamin d", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2221, "treatment_name": "Magnesium sulfate+vitamin d3", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 766, "treatment_name": "Magnesium sulfate", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]